Skip to main content
Equibles

Manchester Capital Management LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1393389 MANCHESTER, VT
Back to ALNY Full portfolio

Position in ALNY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$24,985
-$3,469 QoQ
Shares Held
83
-3.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#656
of 787 holders
Holding Since
Sep 2020
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Manchester Capital Management LLC holds $805,024 across 28 Biotechnology names. ALNY ranks #7 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REPL
Replimune Group, Inc.
 25,675 $284,222
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 391 $194,221
3 INSM
INSMED Inc
 1,033 $110,138
4 RPRX
Royalty Pharma plc
 694 $38,912
5 REGN
Regeneron Pharmaceuticals, Inc.
 47 $29,306
6 ABVX
Abivax S.A.
 200 $26,652
7 ALNY
Alnylam Pharmaceuticals, Inc.
This page 		83 $24,985
8 MRNA
Moderna, Inc.
 321 $22,479

All Filings in ALNY

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,985 83
2026-03-31 $28,454 86
2025-12-31 $33,402 84
2025-09-30 $5,472 12
2025-06-30 $978 3
2025-03-31 $540 2
2024-12-31 $470 2
2024-09-30 $550 2
2024-06-30 $486 2
2024-03-31 $448 3
2023-12-31 $574 3
2023-09-30 $531 3
2023-06-30 $569 3
2020-09-30 $436 3